Drug factory · FDA FEI 3000233845

Nelson Laboratories, LLC

6280 South Redwood Road, Salt Lake City, UT, United States

United States: 1

Problems found, fixed voluntarily at FDA's last inspection, Jun 2, 2023.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

6 drug inspections on record since 2010: 3 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
AfliberceptTests it Regeneron Pharmaceuticals, Inc. 61755-005
AlirocumabTests it Regeneron Pharmaceuticals, Inc. 61755-020, 61755-021
AprepitantTests it Spes Pharmaceuticals Inc. 82243-1001
BuprenorphineTests it Indivior Inc. 12496-0100, 12496-0300
GaretosmabTests it Regeneron Pharmaceuticals, Inc. 61755-012
ObiltoxaximabTests it Elusys Therapeutics, Inc. 69604-204
PegcetacoplanTests it Apellis Pharmaceuticals, Inc. 73606-010
RisperidoneTests it Indivior Inc. 12496-0090, 12496-0120
SarilumabTests it Sanofi-Aventis U.S. LLC 0024-5908, 0024-5910
Sodium Cation, Sodium Bicarbonate, Anhydrous Dextrose, Magnesium Sulfate, PotassTests it Lukare Medical, LLC 55792-007
TeplizumabTests it Provention Bio, Inc. 73650-316
Zopapogene ImadenovecTests it Precigen, Inc. 84768-511

FDA inspection history

EndedResultProgramProblems noted
Jun 2, 2023Problems found, fixed voluntarilyDrug Quality Assurance1
Mar 30, 2018No problems foundDrug Quality Assurance—
Feb 26, 2016No problems foundDrug Quality Assurance1
Jan 10, 2014No problems foundDrug Quality Assurance—
Mar 9, 2012Problems found, fixed voluntarilyDrug Quality Assurance—
Jan 8, 2010Problems found, fixed voluntarilyDrug Quality Assurance—

What inspectors wrote down

From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.

Jun 2, 2023 inspection

Feb 26, 2016 inspection

Registered with FDA for: analysis.